Basic Information
Basic information for ITGA9-AS1-231-16aa-2
Peptide Name ITGA9-AS1-231-16aa-2
Genome Position chr3:37717401-37717448[-]
Species Human
Peptide Sequence MLFERYFLCEYTLFWN
Peptide Length 16
Unique No (ITGA9-AS1-221-16aa-1,ITGA9-AS1-230-16aa-2)
Grand Average of Hydropathicity 0.3125
Relative Molecular Mass 2445.79
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000663533;ITGA9-AS1-231
Transcript Length 3917
Coding Ability 0.457
DNA Sequence Corresponding to Peptide ATGTTATTTGAGAGATATTTCCTGTGTGAGTATACACTTTTCTGGAAC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :